Jiangsu Yongda Pharmaceutical Co., Ltd. is located in Changzhou Binjiang Chemical Zone of beautiful and rich south bank of Yangtze River. It produces over 50 varieties of medical bulk materials and medical intermediates.
Based on domestic famous research institutes and universities, we have formed intensive and large-scale production according to GMP requirements. We have top grade equipments, excellent testing instrument and professional staffs. Currently, our company has become domestic large production base of gatifloxacin. Meanwhile, we have technological superiority and superior production scale in manufacturing of perindopril tert-butylamine salt intermediate, Indoline-2-carboxylic acid series products. Four bulk pharmaceutical materials have passed state GMP authentication. Another two are under application and examination. In addition, we have a great advantage in high-pressure hydrogenation reaction and enzymic catalytic reaction.
40% of our employees are with college degree, bachelor degree or above. In 2003, scientific and technology research institute was established. Since establishment, we continuously develop and research new products, insisting on principle of steady and fast development.